167 related articles for article (PubMed ID: 21140258)
21. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
[TBL] [Abstract][Full Text] [Related]
22. Salvia divinorum use and phenomenology: results from an online survey.
Sumnall HR; Measham F; Brandt SD; Cole JC
J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
[TBL] [Abstract][Full Text] [Related]
23. The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.
Butelman ER; Rus S; Prisinzano TE; Kreek MJ
Psychopharmacology (Berl); 2010 Jun; 210(2):253-62. PubMed ID: 20084367
[TBL] [Abstract][Full Text] [Related]
24. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
25. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain.
Doss MK; May DG; Johnson MW; Clifton JM; Hedrick SL; Prisinzano TE; Griffiths RR; Barrett FS
Sci Rep; 2020 Oct; 10(1):16392. PubMed ID: 33009457
[TBL] [Abstract][Full Text] [Related]
26. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo.
Butelman ER; Caspers M; Lovell KM; Kreek MJ; Prisinzano TE
J Pharmacol Exp Ther; 2012 Jun; 341(3):802-8. PubMed ID: 22434677
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
29. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
[TBL] [Abstract][Full Text] [Related]
30. Salvinorin A: from natural product to human therapeutics.
Vortherms TA; Roth BL
Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
[TBL] [Abstract][Full Text] [Related]
31. Psychopharmacology of the hallucinogenic sage Salvia divinorum.
Prisinzano TE
Life Sci; 2005 Dec; 78(5):527-31. PubMed ID: 16213533
[TBL] [Abstract][Full Text] [Related]
32. A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo.
Phipps SM; Butterweck V
Planta Med; 2010 Sep; 76(13):1405-10. PubMed ID: 20217638
[TBL] [Abstract][Full Text] [Related]
33. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
[TBL] [Abstract][Full Text] [Related]
34. Salvia divinorum: toxicological aspects and analysis in human biological specimens.
Margalho C; Corte-Real F; López-Rivadulla M; Gallardo E
Bioanalysis; 2016 Jul; 8(13):1415-25. PubMed ID: 27277872
[TBL] [Abstract][Full Text] [Related]
35. Chemical syntheses of the salvinorin chemotype of KOR agonist.
Hill SJ; Brion AUCM; Shenvi RA
Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
[TBL] [Abstract][Full Text] [Related]
36. The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A.
Ona G; Sampedro F; Romero S; Valle M; Camacho V; Migliorelli C; Mañanas MÁ; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; Riba J
Int J Neuropsychopharmacol; 2022 Jan; 25(1):54-63. PubMed ID: 34537829
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates.
Schmidt MD; Schmidt MS; Butelman ER; Harding WW; Tidgewell K; Murry DJ; Kreek MJ; Prisinzano TE
Synapse; 2005 Dec; 58(3):208-10. PubMed ID: 16138318
[TBL] [Abstract][Full Text] [Related]
38. From local to global-fifty years of research on Salvia divinorum.
Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
[TBL] [Abstract][Full Text] [Related]
39. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
40. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
Simpson DS; Lovell KM; Lozama A; Han N; Day VW; Dersch CM; Rothman RB; Prisinzano TE
Org Biomol Chem; 2009 Sep; 7(18):3748-56. PubMed ID: 19707679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
